Chromium
In clinical developmentAlso known as Chrom, Chromium, elemental, Cr - chromium, Cromo+1 more
Chrom, Chromium, elemental, Cr - chromium, Cromo, Dinakrome.
Recent clinical, regulatory, research and industry developments relating to this drug.
Multispectral and anatomical assessment of chromium and nickel accumulation in urban weeds
Gut Microbiota and Complications of Type-2 Diabetes.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- International journal of molecular sciences1
- Nutrients1
- Baj J1
- Bargieł J1
- Cabaj J1
- Covasa M1
- Flieger J1
- Hunek G1
- Iatcu CO1
- Portincasa P1
- Clinica Medica "A. Murri"1
- College of Medicine1
- College of Medicine and Biological Sciences1
- College of Osteopathic Medicine1
- Department of Epidemiology and Clinical Research Methodology1
- Medical University of Lublin1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 5 of the same disease areas as Chromium in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials